Fosfomycin IV bulk supplier for pharma manufacturers

Fosfomycin Iv 2 g, 4g per vial Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV)

Available Strengths: 2 g, 4g per vial

Reference Brands: Zyflo(US)

Fosfomycin IV inhibits bacterial cell wall synthesis by targeting the enzyme MurA, preventing peptidoglycan formation. It offers broad-spectrum activity against resistant gram-negative bacteria and carbapenemase producers. Benefits include rapid bactericidal action, high tissue penetration, and effective treatment of complicated urinary and systemic infections, especially when resistance limits other options.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Fosfomycin IV is approved in the EU and US for complicated urinary tract infections and systemic bacterial infections. In the EU, brands like Fosfomycin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generics are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety. To navigate complex regulatory requirements, optimize dossier submission, and ensure compliance, visit PharmaTradz. We facilitate seamless market access for fosfomycin IV, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.

Fosfomycin Iv — third party manufacturing & bulk supply

Fosfomycin Iv 2 g, 4g per vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fosfomycin Iv is supplied as Intravenous (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fosfomycin Iv listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fosfomycin Iv →

Back to Listing

Frequently Asked Questions

Fosfomycin IV is listed as Intravenous (IV) in 2 g, 4g per vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Fosfomycin IV is referenced against Zyflo(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.